Parties d'ouvrages collectifs (6)
  1. 1. Vandenberg, O., & Kozlakidis, Z. (2024). Needs of Healthcare and Medical Research Digitization in Developing Countries: Digital Health Infrastructure. In Needs of Healthcare and Medical Research Digitization in Developing Countries: Digital Health Infrastructure: Digitalization of Medicine in Low- and Middle-Income Countries. Sustainable Development Goals Series. Springer, Cham. springer. doi:10.1007/978-3-031-62332-5_7
  2. 2. Aidara Kane, A., Vandenberg, O., Rahman, M. R., & Butzler, J.-P. (2007). Bacterial Enteric Pathogens: Clostridium difficile, Salmonella, Shigella, Escherichia coli and others. In J.-P. Butzler (Ed.), A Guide to Infection Control in the Hospital. London: B.C. Decker Inc. Hamilton.
  3. 3. Vandenberg, O., Skirrow, M., & Butzler, J.-P. (2005). Arcobacter and Campylobacter. In S. Boriello, P. Murray, & G. Funke (Eds.), Topley and Wilson’s Microbiology and Microbial Infections (10 ed., pp. 1541-1590). London: Hodder Arnold.
  4. 4. Jalal Uddin, S., Vandenberg, O., & Butzler, J.-P. (1998). Bacterial Enteric Pathogens: Salmonella, Shigella, Escherichia coli and others. In J.-P. Butzler (Ed.), A Guide to Infection Control in the Hospital. London: B.C. Decker Inc Hamilton.
  5. 5. Jalal Uddin, S., Vandenberg, O., & Butzler, J.-P. (1998). In vitro activity of Ofloxacine, Ketolides RU 004 and 647, and four other antibiotics against four different Campylobacter spp. In A. Lastovica, D. Newell, & E. Lastovica (Eds.), Campylobacter, Helicobacter and related organisms.. University of Cape Town: Institute of Child Health.
  6. 6. Dediste, A., Aeby, A., Ebraert, A., Vlaes, L., Tridiani, R., Vandenberg, O., Devaster, J.-M., Vandamme, P., & Butzler, J.-P. (1998). Arcobacter in stools: clinical features, diagnosis and antibiotic susceptibility. In A. Lastovica, D. Newell, & E. Lastovica (Eds.), Campylobacter Helicobacter and related organisms. University of Cape Town: Institute of Child Health.
    7.   Articles dans des revues avec comité de lecture (117)
  7. 1. Pirson, M., Brauner, J., Byl, B., Demeester, R., Yin, N., Vincent, M., Leclercq, P., & Vandenberg, O. (2025). Comparaison du coût et de la durée de séjour des bactériémies nosocomiales dues aux bactéries multirésistantes. Une première approche pour évaluer le bénéfice potentiel de la phagothérapie d’un point de vue pharmaco-économique. Revue médicale de Bruxelles,(46), 552-559.
  8. 2. Nguyen, T. B. T., Dahma, H., Dermauw, V., Bui, D. T., Losson, B., Dorny, P., Do, D. T., & Vandenberg, O. (2025). Seroprevalence and associated risk factors of human fascioliasis in Yen Bai and Thanh Hoa provinces, Vietnam. Parasitology international, 112, 103219. doi:10.1016/j.parint.2025.103219
  9. 3. Hatem, M. H., Blavier, A., Alldéen, S. S., Foucart, J., Taxil, B. B., Keyser, L. L., Weyembergh, A., & Vandenberg, O. (2025). Unjustified silence in the face of this new war in eastern DR Congo. Lancet. doi:10.1016/S0140-6736(25)00334-4
  10. 4. Yin, N., Fachqoul, Z., Van Cauteren, D., Van den Wijngaert, S., Martiny, D., Hallin, M., & Vandenberg, O. (2024). Impact of extreme weather events on the occurrence of infectious diseases in Belgium from 2011 to 2021. Journal of Medical Microbiology, 73(7), 001863. doi:10.1099/jmm.0.001863
  11. 5. Botha, J. J., Zafilaza, K., Soulie, C., Yin, N., Spyer, M., Balaska, S., Chatziioannidou, S., Tsiakalou, V., Papadakis, G., Skoura, L., Zafiropoulos, A., Sourvinos, G., Vandenberg, O., Marcelin, A.-G., Gizeli, E., & Nastouli, E. (2024). Evaluation of a near-patient SARS-CoV-2 novel rapid diagnostic platform. Microbiology spectrum, e0067224. doi:10.1128/spectrum.00672-24
  12. 6. Michel, C., Echahidi, F., Place, S., Filippin, L., Colombie, V., Yin, N., Martiny, D., Vandenberg, O., Piérard, D., & Hallin, M. (2024). From Investigating a Case of Cellulitis to Exploring Nosocomial Infection Control of ST1 Legionella pneumophila Using Genomic Approaches. Microorganisms, 12(5), 857. doi:10.3390/microorganisms12050857
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 Suivant >>